Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 11/20 | 0.41 |
| ▸ | CDC25B | P30305 | 9/20 | 0.41 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 6/20 | 0.41 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.38 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.38 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.38 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 5/20 | 0.38 |
| ▸ | GJB2 | P29033 | 2/20 | 0.37 |
| ▸ | CDC25A | P30304 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18308964 | 1.00 | PTPN1 (0.41) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308951 | 0.94 | NT5E (0.45) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308955 | 0.94 | NT5E (0.45) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308948 | 0.86 | NT5E (0.43) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308966 | 0.86 | NT5E (0.43) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308960 | 0.85 | PTPN1 (0.43) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308949 | 0.85 | GJB2 (0.44) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308954 | 0.85 | GJB2 (0.44) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308946 | 0.83 | PTPN1 (0.42) | PTPN1CDC25BNT5EPTPN2PTPN11 | |
| SCHEMBL18308956 | 0.83 | PTPN1 (0.42) | PTPN1CDC25BNT5EPTPN2PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160362437-A1 | Method for Producing Lentztrehalose A, Compound Useful for the Method, and Method for Producing the Compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2016-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362437-A1 | Method for Producing Lentztrehalose A, Compound Useful for the Method, and Method for Producing the Compound | TREH, TALDO1, ST6GAL1 | PTPN1 4261/4885CDC25B 1432/4885NT5E 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.